Shandong Polymer Biochemicals announced that its wholly-owned subsidiary Shandong Polymer Biochemicals participated in the bidding for the 2025 framework agreement for Type II polyacrylamide products organized by the Material Equipment Department of China Petroleum & Chemical Corporation (International Business Company), and has been shortlisted with a tax-excluded bid evaluation price of 0.266 billion yuan, ranking first. The procurement content of this bidding is polymers for oil recovery \ Type II polyacrylamide granules for oil recovery, with a quantity of 0.07705 million tons. Shandong Polymer Biochemicals' bid evaluation price has decreased compared to previous years, and the gross margin for the Type II polyacrylamide products sold to the tenderer is expected to decrease, but the sales volume of this product is expected to increase. The company is currently unable to reasonably estimate the product allocation share and its specific impact on Operation performance. The bidding quantity is an estimated amount, and the final supply quantity from Shandong Polymer Biochemicals is uncertain. Shandong Polymer Biochemicals has not yet signed a formal framework agreement with the tenderer.
宝莫股份:子公司宝莫环境入围中国石化2025年聚丙烯酰胺II型产品框架协议招标候选人名单
Shandong Polymer Biochemicals: The subsidiary Shandong Polymer Biochemicals has been shortlisted in China Petroleum & Chemical Corporation's 2025 framework agreement bidding candidate list for Type II polyacrylamide products.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.